ASXC - Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday? | Benzinga
On Friday, KARL STORZ Endoscopy-America, Inc. agreed to acquire Asensus Surgical Inc. (NYSE:ASXC) for $0.35 per share in cash.
KARL STORZ is a wholly-owned direct subsidiary of KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company based in Germany.
The purchase price represents a premium of approximately 67% based on the per-share closing price of the Asensus common stock on the NYSE American on April 2 and a premium of approximately 52% to the closing price of the common stock on the last ...